510(k) device
Embryogen
Origio A/S · Media, Reproductive (MQL, Class II) · First FDA decision Sep 26, 2012, newest Jun 16, 2014Infertility
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
2
Naming "Embryogen"
MAUDE reports
0
Brand "Embryogen", since 2015
PubMed studies
3
Mentioning "Embryogen"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Embryogen
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- EMBRYOGEN510(k)
K140317 · Decided Jun 16, 2014 · 126 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
- EMBRYOGEN510(k)
K120136 · Decided Sep 26, 2012 · 253 days after receipt
Device type: Media, Reproductive (MQL) · Obstetrics & Gynecology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Embryogen", any status and sponsor, newest update first.
- EmbryoGen/ Blastgen for Couples With Implantation Problems or Previous MiscarriagePivotal-lookingCompleted
FertilitySANot on our public-company list
NCT02305420 · 100 participants · Start Nov 2014 · Primary completion Jun 2017
Device: EmbryoGen/ BlastGen media; Standard Cook sequential media · For: Recurrent Miscarriage; Infertility
Sites: Adelaide, Australia
- Efficacy Study of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) for Use in Human IVFPivotal-lookingCompleted
Origio A/SNot on our public-company list
NCT00565747 · 1,332 participants · Start Nov 2007 · Primary completion Nov 2010
Device: Test culture; Control culture · For: Infertility
Sites: Aarhus, Denmark; Brædstrup, Denmark; Copenhagen, Denmark · 14 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Embryogen", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MQL
13 reports: 5 malfunction, 7 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Embryogen"[tiab]. The summary above synthesizes these.
- The BlastGen study: a randomized controlled trial of blastocyst media supplemented with granulocyte-macrophage colony-stimulating factor.
Rose RD, Barry MF, Dunstan EV, et al. · Reprod Biomed Online · 2020Randomized Controlled Trial
- The frequency of clinical pregnancy and implantation rate after cultivation of embryos in a medium with granulocyte macrophage colony-stimulating factor (GM-CSF) in patients with preceding failed attempts of ART.
Tevkin S, Lokshin V, Shishimorova M, et al. · Gynecol Endocrinol · 2014
- Culture media for human pre-implantation embryos in assisted reproductive technology cycles.
Laverde M, Zagers M, van Wely M, et al. · Cochrane Database Syst Rev · 2026Systematic Review, Meta-Analysis
Other devices of this type
Also filed under product code MQL.
- Scandinavian Ivf Sciences Ab, G2.2Vitrolife AB/Scandinavian Ivf Sciences AB · 510(k) 2000
- Dewin Reproductive Media (Dewin Gamete Buffer [with HSA and without HSA]Donnevie Medical Technology (Shanghai) Co. , Ltd. · 510(k) 2025
- GM501 Wash with Phenol Red and GentamicinHamilton Thorne Incorporated · 510(k) 2020
- SAGE Vitrification Kit (ART-8025 and ART-8026) / SAGE Vitrification Warming Kit (ART-8030 and ART-8031)CooperSurgical, Inc. · 510(k) 2018
- Sydney IVF Sperm Cryopreservation BufferWilliam A. Cook Australia Pty. , Ltd. · 510(k) 2016
- COOK Sydney IVF Blastocyst Vitrification KitWilliam A. Cook Australia Pty. , Ltd. · 510(k) 2015
- Embryoassist and Embryoassist with Phenol RedMedicult A/S · 510(k) 2008
- Vitrification Freeze Kit and Thawing Kit (CS-IVF-FKCell Store (Beijing) Biotechnology Co., Ltd. · 510(k) 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.